Two Sigma Investments, LP Vivos Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.31 - $0.55 $8,590 - $15,241	-27,712 Reduced 30.45%	63,301 $32,000
Q1 2023 May 15, 2023	BUY	$0.32 - $1.88 $29,124 - $171,104	91,013 New	91,013 $30,000
Q1 2022 May 16, 2022	SELL	$1.63 - $3.63 $191,060 - $425,490	-117,215 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.11 $90,245 - $164,847	-40,109 Reduced 25.49%	117,215 $264,000
Q3 2021 Nov 15, 2021	BUY	$2.71 - $5.9 $426,348 - $928,211	157,324 New	157,324 $636,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.